PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

There are other drugs tested that have shown modest cartilage...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,850 Posts.
    lightbulb Created with Sketch. 1265
    There are other drugs tested that have shown modest cartilage regrowth but no clinical improvement in pain or function. FDA guidelines indicate you need all for obvious reasons. EMA and TGA are going to be very impressed with our results here. Looking to see if PR can contain his excitement today.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.